Get the Stockscreener App
1.20
6.25%
-0.08
After Hours:
1.23
0.03
+2.50%
Tenaya Therapeutics Inc stock is traded at $1.20, with a volume of 3.47M.
It is down -6.25% in the last 24 hours and up +58.52% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$1.28
Open:
$1.28
24h Volume:
3.47M
Relative Volume:
1.13
Market Cap:
$195.57M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-0.9091
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
-11.11%
1M Performance:
+58.52%
6M Performance:
+99.90%
1Y Performance:
-41.75%
1-Day Range:
$1.18
$1.3086
1-Week Range:
$1.18
$1.43
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.20 | 211.87M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Tenaya Therapeutics Stays Speculative As Trials And Dilution Weigh On Shares - Finimize
226,202 Shares in Tenaya Therapeutics, Inc. $TNYA Bought by Nuveen LLC - MarketBeat
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores SurgeInflaRx (NASDAQ:IFRX), Alector (NASDAQ:ALEC) - Benzinga
Tenaya Therapeutics (NASDAQ:TNYA) Given Buy Rating at HC Wainwright - MarketBeat
Short interest data insights for Tenaya Therapeutics Inc.Earnings Trend Report & Advanced Swing Trade Entry Alerts - Newser
Why Tenaya Therapeutics Inc. is moving todayPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Does Tenaya Therapeutics Inc. stock have upside surprise potentialRate Cut & AI Enhanced Market Trend Forecasts - خودرو بانک
Can Tenaya Therapeutics Inc. reach all time highs this yearWeekly Volume Report & Verified Momentum Stock Watchlist - خودرو بانک
What’s next for Tenaya Therapeutics Inc. stock price2025 Key Lessons & Long-Term Capital Growth Strategies - Newser
Can Tenaya Therapeutics Inc. deliver consistent EPS growth2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - خودرو بانک
Published on: 2025-09-05 14:07:00 - Newser
Applying big data sentiment scoring on Tenaya Therapeutics Inc.2025 Sector Review & Low Risk High Reward Ideas - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookQuarterly Portfolio Summary & Community Verified Watchlist Alerts - Newser
Regression analysis insights on Tenaya Therapeutics Inc. performanceJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - Newser
What’s the recovery path for long term holders of Tenaya Therapeutics Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - Newser
Long term hold vs stop loss in Tenaya Therapeutics Inc.July 2025 Closing Moves & Technical Analysis for Trade Confirmation - Newser
Using AI based signals to follow Tenaya Therapeutics Inc.2025 Market Trends & Safe Swing Trade Setups - Newser
Will Tenaya Therapeutics Inc. rebound enough to break evenJuly 2025 Sector Moves & Growth Focused Entry Reports - Newser
Is Tenaya Therapeutics Inc. a defensive stock2025 Year in Review & Fast Exit/Entry Strategy Plans - خودرو بانک
Will Tenaya Therapeutics Inc. see short term momentumJuly 2025 Update & Safe Entry Point Alerts - Newser
Earnings visualization tools for Tenaya Therapeutics Inc.Trade Exit Summary & Short-Term High Return Ideas - Newser
Risk Check: Is Tenaya Therapeutics Inc. a defensive stock2025 Volume Leaders & Community Trade Idea Sharing Platform - خودرو بانک
Is a relief rally coming for Tenaya Therapeutics Inc. holdersWeekly Stock Recap & Weekly High Return Forecasts - Newser
Historical volatility pattern of Tenaya Therapeutics Inc. visualizedJuly 2025 Fed Impact & Consistent Profit Trading Strategies - Newser
Tenaya Therapeutics shares rise 6.94% intraday after CEO to participate in Morgan Stanley conference. - AInvest
Signal strength of Tenaya Therapeutics Inc. stock in tech scanners2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
Is Tenaya Therapeutics Inc. part of any major indexBond Market & AI Enhanced Trading Alerts - خودرو بانک
How moving averages guide Tenaya Therapeutics Inc. tradingFed Meeting & Risk Managed Investment Entry Signals - Newser
Will Tenaya Therapeutics Inc. stock go up soon2025 Price Targets & Daily Market Momentum Tracking - Newser
News impact scoring models applied to Tenaya Therapeutics Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - Newser
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Heart Disease Biotech Tenaya Therapeutics Featured at Morgan Stanley Global Healthcare Conference 2025 - Stock Titan
Best data tools to analyze Tenaya Therapeutics Inc. stock2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Layoff Watch: Can Tenaya Therapeutics Inc. reach all time highs this yearBuy Signal & Fast Exit Strategy with Risk Control - خودرو بانک
What’s the analyst consensus on Tenaya Therapeutics Inc.Product Launch & Consistent Profit Alerts - خودرو بانک
Tenaya Therapeutics Inc. stock momentum explained2025 Biggest Moves & AI Forecast for Swing Trade Picks - Newser
How to read the order book for Tenaya Therapeutics Inc.2025 Price Targets & Community Consensus Picks - Newser
Published on: 2025-09-01 18:04:09 - خودرو بانک
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):